Does anything stated here require piercing the corporate veil?

Quote:

---

Among other issues, following the discovery of certain specific oversights associated with a prior submission to the FDA, it became increasingly apparent to CytoDyn that Amarex was not performing its services on par with industry standards or in some cases not at all. Over the past 12 months, we were able to obtain a 3rd party audit, which we discussed previously, which confirms these suspicions and uncovered significant non performance and under performance by Amarex. We believe that this conduct and underperformance results in a clear breach of contractural agreements between the 2 parties. We are in the process of seeking damages related to that breach of contract. In terms of where we are from a proceeding stand point. We have already filed the claim against Amarex. In those proceedings, among other claims for damages, we would be seeking reimbursement for services that were invoiced by Amarex and simply never performed and services that were negligent or services that were performed well below industry standard . We continue to pursue that. this case and we look forward to the opportunity to present more fully, but do to the fact that this is still pending legal matter, there is not much more we can say at this time.

---

One reason may be imbedded in the words, "... among other claims for damages ..."

The above was taken from: 4/11/23 Webcast